Furthermore, clinical evidence showing that genetic FOXO1 variants are associated with insulin resistance and type 2 diabetes also supports the contribution of FOXO1 in glucose metabolism in humans [23]. This evidence concerns the gene FOXO1 and Insulin resistance.